Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

PHASE4TerminatedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

November 30, 2007

Conditions
Epilepsies, Partial
Interventions
DEVICE

Vagus Nerve Stimulation Therapy

Trial Locations (23)

10021

Weill-Cornell Medical College, N.Y. Presbyterian Hospital, Comprehensive Epilepsy Center, New York

18015

Neurology and Sleep Medicine, Bethlehem

28801

William Huffstutter, M.D., Asheville

32504

Child Neurology Center of Northwest Florida, Pensacola

32610

University of Florida, Department of Neurology, Gainesville

32751

Neurology Associates, P.A., Maitland

38138

Mid-South Physicians Group, P.L.L.C., Germantown

48201

Wayne State University School of Medicine, Department of Neurology, Detroit

53215

Regional Epilepsy Center Saint Luke's Medical Center, Milwaukee

61032

Freeport Health Network, Department of Neurology, Freeport

77030

Hermann Hospital, UT Comprehensive Epilepsy Center, Houston

78258

Texas Association of Pediatric Neurology, San Antonio

79430

Texas Tech University Health Sciences Center, Lubbock

83712

Pediatric Neurology of Idaho, Boise

84047

Pivotal Research Centers, Midvale

84403

Pharmaceutical Research Organization, South Ogden

85003

Bronislav Shafran, M.D., P.C., Phoenix

85013

Xenoscience, Phoenix

85351

Dedicated Clinical Research, Inc., Sun City

90033

USC Comprehensive Epilepsy Center, Los Angeles

93003

Pediatric Diagnostic Center, Ventura

95661

Certified Clinical Research, Roseville

997504

Medford Neurological and Spine Clinic, Medford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cyberonics, Inc.

INDUSTRY

NCT00215215 - Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures | Biotech Hunter | Biotech Hunter